WIMI News
Archived Headlines
- China's WiMi Hologram ups ADS offering, cuts range on $33 million US IPO 03/23/20
- US IPO Week Ahead: IPO filings heat up amid annual August break 08/16/19
- US IPO Week Ahead: A Kansas bank and a Chinese fintech wrap up the summer IPO market 08/09/19
- US IPO Week Ahead: Summer's last wave with 5 IPOs 08/02/19
- US IPO Weekly Recap: Sushi and SaaS succeed in a 4-IPO week 08/02/19
See more
US IPO Week Ahead: Another quiet week for the IPO market with 1 biotech
Updated on Monday, April 20, 2020. One biotech IPO is scheduled for the week ahead, and pipeline activity indicates that a few more may be on the way. ORIC Pharmaceuticals (ORIC), a Phase 1 biotech developing small molecule therapies for...read more
US IPO Weekly Recap: Zentalis Pharma defies sell-off as biotech pops 29%
The biotech industry refuses to wait. This past week saw the first IPOs since the coronavirus outbreak seized the US economy, with oncology biotech Zentalis Pharmaceuticals (ZNTL) up 29% on its first day. The IPO Index slid 8% this week,...read more
Chinese augmented reality platform WiMi Hologram prices US IPO at $5.50 low end
WiMi Hologram Cloud, a Chinese provider of holographic augmented reality software for advertising, raised $26 million by offering 4.8 million ADSs at $5.50, the low end of the range of $5.50 to $7.50, to command a market value of $325 million. The company had...read more
US IPO Week Ahead: A biotech and a Chinese hologram company take on a tough IPO market
Updated Monday, March 30, 2020. A biotech and a Chinese issuer are tackling a tough US IPO market in the week ahead. WiMi Hologram Cloud (WIMI) plans to raise $33 million at a $385 million market cap, underwritten by The Benchmark...read more